XSHE
002250
Market cap1.94bUSD
Oct 09, Last price
14.60CNY
1D
1.18%
1Q
1.81%
Jan 2017
-9.77%
IPO
566.67%
Name
Lianhe Chemical Technology Co Ltd
Chart & performance
P/E
36.30
P/S
2.04
EPS
0.40
Div yield, %
0.14%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
6.10%
Revenues
6.43b
+13.27%
Net income
362m
+250.93%
CFO
1.14b
-8.23%
Dividend
Jul 09, 20260.2 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating from its base in Taizhou, China, Lianhe Chemical Technology Co., Ltd. is a company established in 1985 that engages in the development, production, commercialization, and sale of chemical goods across China. Its extensive product range encompasses crop protection solutions, specialized industrial chemicals, and pharmaceutical ingredients. Furthermore, the company extends its services to include engineering solutions and the fabrication of necessary equipment.
Key people
Ping Wang
Chairman of the Board, President · since 2020
Yunxuan Xue
Chief Financial Officer · since 2021
Feibiao Chen
Senior Vice President, Secretary of the Board · since 2016
Xiaobin Fan
Senior Vice President, Director · since 2023
Chun He
Senior Vice President, Director · since 2020
Gang Chen
Independent Director · since 2025
Meng Jiang
Independent Director · since 2019
Shouyun Yu
Independent Director · since 2019
Yun Zhang
Independent Director · since 2022
Headquarters & legal address
浙江省台州市黄岩区经济开发区永椒路8号
台州市, ZJ 100000
CN
台州市, ZJ 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||